Form 8-K - Current report:
SEC Accession No. 0001193125-25-054049
Filing Date
2025-03-13
Accepted
2025-03-13 17:19:05
Documents
21
Period of Report
2025-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935304d8k.htm   iXBRL 8-K 47485
2 EX-4.1 d935304dex41.htm EX-4.1 614715
7 GRAPHIC g935304g0311111859702.jpg GRAPHIC 2043
8 GRAPHIC g935304g0311111900310.jpg GRAPHIC 2515
9 GRAPHIC g935304g0311111900851.jpg GRAPHIC 2388
10 GRAPHIC g935304g0311111901407.jpg GRAPHIC 2522
11 GRAPHIC g935304g0311111901978.jpg GRAPHIC 2926
12 GRAPHIC g935304g92v71.jpg GRAPHIC 2992
  Complete submission text file 0001193125-25-054049.txt   984083

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dvax-20250313.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20250313_def.xml EX-101.DEF 13673
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20250313_lab.xml EX-101.LAB 22622
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20250313_pre.xml EX-101.PRE 14641
24 EXTRACTED XBRL INSTANCE DOCUMENT d935304d8k_htm.xml XML 5486
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 25736886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)